Night-time frequency of urination as a manifestation of sleep-disordered breathing: the Nagahama study.

General population Night-time frequency of urination Risk score Sleep-disordered breathing

Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 05 2020
revised: 28 07 2020
accepted: 03 09 2020
pubmed: 4 10 2020
medline: 22 6 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

Sleep-disordered breathing (SDB) is a well-known risk factor for cardiovascular outcomes. Studies of patients with SDB have identified frequent night-time urination as a manifestation related to SDB. We aimed to clarify whether night-time frequency of urination is independently associated with SDB in a general population. We also investigated whether night-time frequency of urination can help presumptive diagnose SDB. Study participants consisted of 7151 community residents. Oxygen saturation during sleep was measured for four nights using a pulse oximeter. SDB was defined as ≥15 events per hour in which oxygen desaturation exceeded or equal to 3% during an actigraphy-determined sleep period. Night-time frequency of urination was recorded for one week using a sleep diary. Significant positive correlations were evident between night-time frequency of urination and SDB (none, 5.8%; once/night, 14.1%; twice/night, 20.1%; thrice/night, 28.7%; >thrice/night, 44.1%, P < 0.001). This association was independent of possible covariates, including sleep duration (adjusted odds ratio: once/night = 1.50, twice/night = 2.15, thrice/night = 3.07, >thrice/night = 3.73, P < 0.001). Other factors significantly associated with SDB were age, sex, obesity, observation of sleep apnea, and short sleep duration. The area under the curve of the risk score for SDB consisting of these conventional six items (0.834) significantly improved (0.842, P = 0.001) when night-time frequency of urination was considered as a risk score item. Night-time frequency of urination was associated with SDB. Our findings suggest that the urination frequency should be considered a manifestation of SDB even in a general population.

Identifiants

pubmed: 33008732
pii: S1389-9457(20)30410-X
doi: 10.1016/j.sleep.2020.09.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

288-294

Investigateurs

Yasuharu Tabara (Y)
Takahisa Kawaguchi (T)
Kazuya Setoh (K)
Yoshimitsu Takahashi (Y)
Shinji Kosugi (S)
Takeo Nakayama (T)
Fumihiko Matsuda (F)
Takuma Minami (T)
Naomi Takahashi (N)
Hirofumi Takeyama (H)
Satoshi Morita (S)
Tomohiro Handa (T)
Naoko Komenami (N)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Satoshi Hamada (S)

Department of Advanced Medicine for Respiratory Failure, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yasuharu Tabara (Y)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan; Research Support Center, Shizuoka General Hospital, Aoi-ku, Shizuoka, Japan. Electronic address: tabara@genome.med.kyoto-u.ac.jp.

Kimihiko Murase (K)

Department of Respiratory Care and Sleep Control Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takeshi Matsumoto (T)

Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Respiratory Medicine, Saiseikai-Noe Hospital, Osaka, Japan.

Kazuya Setoh (K)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Tomoko Wakamura (T)

Department of Nursing Science, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takahisa Kawaguchi (T)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Shinji Kosugi (S)

Department of Medical Ethics and Medical Genetics, Kyoto University School of Public Health, Kyoto, Japan.

Takeo Nakayama (T)

Research Support Center, Shizuoka General Hospital, Aoi-ku, Shizuoka, Japan; Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.

Toyohiro Hirai (T)

Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Fumihiko Matsuda (F)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan; Research Support Center, Shizuoka General Hospital, Aoi-ku, Shizuoka, Japan.

Kazuo Chin (K)

Department of Respiratory Care and Sleep Control Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH